唾液腺感染疾病市场规模、份额、成长分析（依感染类型、受累腺体、诊断方法、治疗类型、最终用户、地区划分）－2025-2032年产业预测

2023 年全球唾液腺感染疾病市场价值为 59 亿美元，预计从 2024 年的 64.4 亿美元成长到 2032 年的 129.2 亿美元，在预测期（2025-2032 年）内复合年增长率为 9.1%。

唾液腺感染疾病市场正经历显着成长，这主要得益于几个关键因素。口腔感染疾病的增加，尤其是在老年族群中，推动了对专业治疗的需求。唾液内视镜和唾液检测等诊断工具的创新，提高了早期发现率，使及时介入更加可行。公众口腔卫生意识的提高以及微创治疗方法的普及，正在积极影响患者的认知和选择。此外，已开发地区医疗基础设施的改善以及新兴市场医疗设施的普及，正在加速该领域的进步。这些因素共同重塑了市场格局，并为治疗和预防领域的创新创造了充满活力的环境，从而推动了市场扩张。

全球唾液腺感染疾病市场驱动因素

口腔感染疾病，尤其是细菌性涎腺炎和病毒性腮腺炎的日益普遍，正显着推动唾液腺感染疾病治疗市场的需求成长。造成此现象的因素包括口腔卫生状况不佳、人口老化、以及糖尿病等全身性疾病的流行。随着社会对这些问题的认识不断提高，寻求早期疗育的患者人数也不断增加。这种日益增长的需求促使医疗系统更加重视快速诊断和针对唾液腺感染疾病的专科治疗，最终推动市场成长并改善患者预后。

全球唾液腺感染疾病市场限制因素

由于农村和医疗资源匮乏地区民众对唾液腺感染疾病市场面临严峻挑战，影响了此类感染疾病的早期发现和及时治疗。这种认知不足导致对症状的误解和病人资讯不足，进而造成漏报和就诊延误。因此，这种认知差距阻碍了医疗保健服务的公平获取，并限制了某些地区的成长机会。解决这个问题对于改善不同族群的健康状况和促进唾液腺感染疾病的更有效管理至关重要。

全球唾液腺感染疾病市场趋势

全球唾液腺感染疾病市场正经历着一场变革性的趋势，即采用微创诊断技术，例如唾液腺内视镜检查。这些创新方法因其在提高诊断准确性的同时最大限度地减少患者不适并加快康復速度，正日益受到医疗服务提供者和患者的青睐。随着临床医生逐渐认识到这些先进技术的优势，它们融入日常临床实践预计将显着推动市场成长。这一趋势不仅反映了以患者为中心的医疗保健解决方案的更广泛趋势，也凸显了技术进步在改善唾液腺感染疾病治疗效果方面的潜力。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球唾液腺感染疾病市场规模（按感染类型和复合年增长率划分）（2025-2032 年）

• 市场概览
• 细菌感染
• 病毒感染
• 霉菌感染疾病
• 寄生虫感染

全球唾液腺感染疾病市场规模：依受影响腺体和复合年增长率划分（2025-2032 年）

• 市场概览
• 腮腺感染疾病
• 下颔腺感染疾病
• 舌下腺感染疾病
• 小唾液腺感染疾病

全球唾液腺感染疾病市场规模（按诊断方法和复合年增长率划分）（2025-2032 年）

• 市场概览
• 身体检查
• 影像技术
• 实验室检查
• 切片检查/造影

全球唾液腺感染疾病市场规模（按治疗类型和复合年增长率划分）（2025-2032 年）

• 市场概览
• 药物
• 外科手术
• 抽吸/引流
• 居家护理/辅助护理

全球唾液腺感染疾病市场规模（按最终用户和复合年增长率划分）（2025-2032 年）

• 市场概览
• 医院和诊所
• 门诊手术中心
• 口腔颚颜面诊所
• 居家照护/远端医疗

全球唾液腺感染疾病市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• AbbVie Inc.
• Allergan
• AstraZeneca
• FUJIFILM Holdings Corporation
• GlaxoSmithKline plc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Siemens Healthcare GmbH
• General Electric Company（GE Healthcare）
• Roche Holding AG
• Takeda Pharmaceutical Company
• Stryker Corporation
• Zimmer Biomet Holdings
• Philips Healthcare
• Canon Medical Systems Corporation
• Hologic Inc.
• Olympus Corporation
• BD
• Varian Medical Systems

结论与建议

Global Salivary Gland Infection Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.44 billion in 2024 to USD 12.92 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The salivary gland infection market is experiencing significant growth driven by several key factors. Rising incidences of oral infections, particularly among older populations, are amplifying the need for specialized treatments. Innovations in diagnostic tools such as sialendoscopy and saliva testing are enhancing early detection, making timely intervention more feasible. Increased public awareness regarding oral health and the availability of less invasive treatment options are positively influencing patient perceptions and choices. Furthermore, improved healthcare infrastructure in developed regions and greater access to medical facilities in emerging markets are accelerating advancements in the field. Collectively, these factors are reshaping the salivary gland infection landscape, fostering a dynamic environment for treatment and prevention innovations, and propelling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Salivary Gland Infection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Salivary Gland Infection Market Segments Analysis

Global Salivary Gland Infection Market is segmented by Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User and region. Based on Type of Infection, the market is segmented into Bacterial Infections, Viral Infections, Fungal Infections and Parasitic Infections. Based on Gland Affected, the market is segmented into Parotid Gland Infections, Submandibular Gland Infections, Sublingual Gland Infections and Minor Salivary Gland Infections. Based on Diagnosis Method, the market is segmented into Physical Examination, Imaging Techniques, Laboratory Testing and Biopsy / Sialography. Based on Treatment Type, the market is segmented into Medication, Surgical Procedures, Aspiration / Drainage and Home Care / Supportive Therapy. Based on End-User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Oral & Maxillofacial Clinics and Home Care / Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Salivary Gland Infection Market

The growing incidence of oral infections, particularly bacterial sialadenitis and viral parotitis, significantly fuels the demand for treatments in the salivary gland infection market. Contributing factors include declining oral health, aging populations, and the prevalence of systemic conditions like diabetes. As public awareness of these issues continues to expand, an increasing number of patients are motivated to pursue early intervention. This rising demand places pressure on healthcare systems to focus on prompt diagnosis and specialized therapies aimed at addressing complications associated with salivary gland infections, ultimately driving market growth and improving patient outcomes.

Restraints in the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market faces significant challenges due to limited awareness in rural and underserved communities, which affects the early detection and prompt treatment of these infections. This lack of awareness leads to varying interpretations of symptoms and inadequate patient information, resulting in underreporting and delayed medical attention. Consequently, this gap in awareness creates obstacles to achieving equitable healthcare access and presents a barrier to growth opportunities within specific regions. Addressing this issue is crucial for improving health outcomes and facilitating better management of salivary gland infections across diverse populations.

Market Trends of the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market is witnessing a transformative trend towards the adoption of minimally invasive diagnostic techniques, such as sialendoscopy. These innovative methods enhance diagnostic accuracy while minimizing patient discomfort and expediting recovery times, making them increasingly attractive to both healthcare providers and patients. As clinicians recognize the benefits of these advanced procedures, their integration into routine clinical practices is expected to drive substantial growth in the market. This shift not only reflects a broader trend toward patient-centric healthcare solutions but also underscores the potential for technological advancements to improve treatment outcomes in salivary gland infections.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Salivary Gland Infection Market Size by Type of Infection & CAGR (2025-2032)

• Market Overview
• Bacterial Infections
• Viral Infections
• Fungal Infections
• Parasitic Infections

Global Salivary Gland Infection Market Size by Gland Affected & CAGR (2025-2032)

• Market Overview
• Parotid Gland Infections
• Submandibular Gland Infections
• Sublingual Gland Infections
• Minor Salivary Gland Infections

Global Salivary Gland Infection Market Size by Diagnosis Method & CAGR (2025-2032)

• Market Overview
• Physical Examination
• Imaging Techniques
• Laboratory Testing
• Biopsy / Sialography

Global Salivary Gland Infection Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Medication
• Surgical Procedures
• Aspiration / Drainage
• Home Care / Supportive Therapy

Global Salivary Gland Infection Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Oral & Maxillofacial Clinics
• Home Care / Telemedicine

Global Salivary Gland Infection Market Size & CAGR (2025-2032)

• North America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • US
  • Canada
• Europe (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (GE Healthcare)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations